We established personalized validation programs for various modalities, including mAb, bis-Ab, ADCs, and antibody fusion proteins, to identify effective and superior antibody leads with high drug-ability. Our expert team, consist of clinical medical experts, pharmaceutical experts, and R&D scientists, ensure our quality in efficacy and safety evaluation. We provide professional solutions, expedited plans and optimization suggestions, that tailored to each individual projects and effectively address technical challenges, to promote the R&D of new antibody drugs in a faster and better way.

systematic

personalized